Literature DB >> 19223101

[Incidence and microbiology of infectious complications with the use of artificial skin Integra in burns].

L Bargues1, S Boyer, T Leclerc, P Duhamel, E Bey.   

Abstract

Integra dermal substitute is used as biomaterial after thermal injury. This artificial skin allows temporary coverage after burns excision, transformation of matrix in neo dermis and definitive engraftment. Infections are the most common complication of this technique. The objectives were to evaluate incidence of sepsis, to analyse microbiology and risk factors of developing Integra infections. Patients with acute burns and indications of Integra during five years were retrospectively enrolled. Demographic data, surgical procedures and microbiologic biopsies were collected. Fifty patients (40 + or - 15 years) were studied and 71 surgical procedures using Integra were performed. Burns were extended 45 + or - 21% total body surface area. Placement of Integra was made 15 + or - 11 days after burns and autografts 31 + or - 9 days after placement of Integra. Twenty-one patients had infected Integra (42% of population). A total of 23 Integra infected sites were observed (15 local and eight invasive). Diagnosis of infection was made after 13 + or - 5 days using quantitative cultures. Other sites of infection were respiratory tract (46 pneumonias) and others burned wounds (17 infections outside of Integra. Any risk factor was identified between burns who developed Integra infections and the others. Incidence of infected Integra was higher than in previous studies. Delayed application of Integra after burns could explain higher incidence of infection. Pseudomonas aeruginosa and Staphylococcus aureus were more frequently isolated than other pathogens. Standardized technique for wounds coverage with Integra is necessary to reduce incidence of infections and improve functional results in burns patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19223101     DOI: 10.1016/j.anplas.2008.10.013

Source DB:  PubMed          Journal:  Ann Chir Plast Esthet        ISSN: 0294-1260            Impact factor:   0.660


  7 in total

1.  [Giant squamous cell carcinoma of the scalp: successful excision with use of bovine dermal substitute].

Authors:  M Zutt; S Ischebeck; K M Kaune
Journal:  Hautarzt       Date:  2013-12       Impact factor: 0.751

2.  A new option for definitive burn wound closure - pair matching type of retrospective case-control study of hand burns in the hospitalised patients group in the Dr Stanislaw Sakiel Centre for Burn Treatment between 2009 and 2015.

Authors:  Justyna Glik; Marek Kawecki; Diana Kitala; Agnieszka Klama-Baryła; Wojciech Łabuś; Marek Grabowski; Agata Durdzińska; Mariusz Nowak; Marcelina Misiuga; Aleksandra Kasperczyk
Journal:  Int Wound J       Date:  2017-02-21       Impact factor: 3.315

3.  Combination of stromal cell-derived factor-1 and collagen-glycosaminoglycan scaffold delays contraction and accelerates reepithelialization of dermal wounds in wild-type mice.

Authors:  Aparajita Sarkar; Soner Tatlidede; Saja Sandra Scherer; Dennis P Orgill; François Berthiaume
Journal:  Wound Repair Regen       Date:  2010-12-06       Impact factor: 3.617

Review 4.  Infectious Complications Associated with the Use of Integra: A Systematic Review of the Literature.

Authors:  Santiago R Gonzalez; Keith G Wolter; James C Yuen
Journal:  Plast Reconstr Surg Glob Open       Date:  2020-07-15

5.  Long-term followup of dermal substitution with acellular dermal implant in burns and postburn scar corrections.

Authors:  I Juhasz; B Kiss; L Lukacs; I Erdei; Z Peter; E Remenyik
Journal:  Dermatol Res Pract       Date:  2010-12-30

6.  Use of dermal regeneration templates in a low resource environment.

Authors:  Tom Potokar; Pippa Anderson
Journal:  Scars Burn Heal       Date:  2016-11-07

Review 7.  Skin tissue engineering advances in severe burns: review and therapeutic applications.

Authors:  Alvin Wen Choong Chua; Yik Cheong Khoo; Bien Keem Tan; Kok Chai Tan; Chee Liam Foo; Si Jack Chong
Journal:  Burns Trauma       Date:  2016-02-19
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.